A detailed history of Envestnet Asset Management Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Envestnet Asset Management Inc holds 1,445,521 shares of TAK stock, worth $19.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,445,521
Previous 1,483,493 2.56%
Holding current value
$19.6 Million
Previous $19.2 Million 7.0%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$13.0 - $15.08 $493,636 - $572,617
-37,972 Reduced 2.56%
1,445,521 $20.5 Million
Q2 2024

Aug 08, 2024

SELL
$12.6 - $13.67 $578,264 - $627,370
-45,894 Reduced 3.0%
1,483,493 $19.2 Million
Q1 2024

May 13, 2024

SELL
$13.89 - $15.04 $825,427 - $893,767
-59,426 Reduced 3.74%
1,529,387 $21.2 Million
Q4 2023

Feb 13, 2024

BUY
$13.36 - $15.43 $1.01 Million - $1.17 Million
75,877 Added 5.02%
1,588,813 $22.7 Million
Q3 2023

Nov 13, 2023

BUY
$15.03 - $16.32 $1.22 Million - $1.33 Million
81,267 Added 5.68%
1,512,936 $23.4 Million
Q2 2023

Aug 04, 2023

SELL
$15.57 - $17.11 $50.9 Million - $55.9 Million
-3,267,934 Reduced 69.54%
1,431,669 $22.5 Million
Q1 2023

May 11, 2023

BUY
$15.28 - $16.48 $54.9 Million - $59.2 Million
3,593,286 Added 324.8%
4,699,603 $77.4 Million
Q4 2022

Feb 07, 2023

BUY
$12.42 - $15.62 $2.69 Million - $3.38 Million
216,445 Added 24.32%
1,106,317 $17.3 Million
Q3 2022

Nov 10, 2022

BUY
$12.8 - $28.65 $4.16 Million - $9.32 Million
325,262 Added 57.61%
889,872 $11.5 Million
Q2 2022

Aug 03, 2022

BUY
$13.12 - $15.03 $887,043 - $1.02 Million
67,610 Added 13.6%
564,610 $7.93 Million
Q1 2022

May 04, 2022

BUY
$13.54 - $15.35 $922,967 - $1.05 Million
68,166 Added 15.9%
497,000 $7.12 Million
Q4 2021

Feb 04, 2022

SELL
$13.17 - $16.4 $62,215 - $77,473
-4,724 Reduced 1.09%
428,834 $5.85 Million
Q3 2021

Oct 07, 2021

BUY
$16.3 - $17.26 $352,080 - $372,816
21,600 Added 5.24%
433,558 $7.1 Million
Q2 2021

Aug 04, 2021

SELL
$16.55 - $18.64 $580,325 - $653,611
-35,065 Reduced 7.84%
411,958 $6.93 Million
Q1 2021

May 04, 2021

BUY
$16.71 - $19.9 $310,922 - $370,279
18,607 Added 4.34%
447,023 $8.16 Million
Q4 2020

Feb 02, 2021

BUY
$15.39 - $18.97 $1.05 Million - $1.3 Million
68,397 Added 19.0%
428,416 $7.8 Million
Q3 2020

Oct 09, 2020

BUY
$17.1 - $19.19 $4,275 - $4,797
250 Added 0.07%
360,019 $6.42 Million
Q2 2020

Jul 08, 2020

BUY
$14.59 - $19.5 $61,774 - $82,563
4,234 Added 1.19%
359,769 $6.45 Million
Q1 2020

Apr 23, 2020

BUY
$13.02 - $20.31 $712,610 - $1.11 Million
54,732 Added 18.2%
355,535 $5.4 Million
Q4 2019

Feb 11, 2020

BUY
$16.88 - $20.83 $320,162 - $395,082
18,967 Added 6.73%
300,803 $5.94 Million
Q3 2019

Oct 17, 2019

BUY
$16.15 - $17.99 $457,335 - $509,440
28,318 Added 11.17%
281,836 $4.85 Million
Q2 2019

Aug 02, 2019

BUY
$16.58 - $20.49 $915,000 - $1.13 Million
55,187 Added 27.83%
253,518 $4.49 Million
Q1 2019

May 10, 2019

BUY
$16.7 - $21.52 $1.47 Million - $1.89 Million
87,781 Added 79.4%
198,331 $4.04 Million
Q4 2018

Feb 13, 2019

BUY
$15.64 - $21.1 $1.73 Million - $2.33 Million
110,550 New
110,550 $1.86 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.